Medical Hypotheses
Volume 59, Issue 3 , Pages 297-301 , September 2002

Potential role of advanced glycosylation end products in promoting restenosis in diabetes and renal failure

  • Doron Aronson

      Affiliations

    • Corresponding Author InformationCorrespondence to: Doron Aronson MD, Department of Cardiology, Rambam Medical Center, P.O. Box 9602, Haifa 31096, Israel. Phone: +972-48-542790; Fax: +972-48-542176

Received 20 December 2001 ,Accepted 4 April 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0306-9877(02)00172-X

Medical Hypotheses
Volume 59, Issue 3 , Pages 297-301 , September 2002